Court Upholds FDA’s Authority Over Homeopathic Drugs, Leaving Industry with Few Remedies
In a closely watched decision, the U.S. District Court for the District of Columbia on July 15, 2025, largely upheld the Food and Drug Administration’s (FDA) authority to regulate homeopathic drugs as “new drugs” under the Federal Food, Drug, and Cosmetic Act—effectively reinforcing the agency’s risk-based enforcement approach finalized in 2022. The lawsuit, brought […]